[TRENDING NEWS] Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit

Author: BY MIHIR ZAVERI AND KATIE THOMAS - Publish Date: October 9, 2019 at 08:47AM

A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.